Thyroid Gland Medullary Carcinoma clinical trials
14 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
- Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
- A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
- Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer
- Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
- Natural History Study of Children and Adults With Medullary Thyroid Cancer
- Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers
- STAGE-MTC Trial Thyroid Lobectomy With Ipsilateral Central Neck Dissection
- 211At-MABG in Adults With Advanced Neuroendocrine Cancers
- A Detailed Look At What Patients Experience In Medullary Thyroid Cancer Clinical Study
- Database Linkage Study to Evaluate the Risk of Medullary Thyroid Carcinoma
- An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
- Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Thyroid Gland Medullary Carcinoma” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.